-
1
-
-
19344366484
-
Systematic overview of warfarin and its drug and food interactions
-
A.M.HolbrookJ.A.PereiraR.Labiris. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med2005;165:1095-106.
-
(2005)
Arch Intern Med
, vol.165
, pp. 1095-1106
-
-
Holbrook, A.M.1
Pereira, J.A.2
Labiris, R.3
-
2
-
-
33750004841
-
Warfarin: almost 60 years and still causing problems
-
M.PirmohamedWarfarin: almost 60 years and still causing problems. Br J Clin Pharmacol2006;62:209-511.
-
(2006)
Br J Clin Pharmacol
, vol.62
, pp. 209-511
-
-
Pirmohamed, M.1
-
3
-
-
85079937100
-
-
February,,. Revised
-
Eliquis Production Monograph, Pfizer Canada Inc, Kirkland, Quebec, and Bristol-Myers Squibb Canada, Montreal Quebec. Revised February20, 2015.
-
(2015)
-
-
-
4
-
-
85079984643
-
-
January,,. Revised
-
Pradaxa Production Monograph, Boehringer Ingelheim Canada Ltd, Burlington, Toronto. Revised January7, 2015.
-
(2015)
-
-
-
5
-
-
85079998724
-
-
February,,. Revised
-
Xarelto Product Monograph, Bayer Inc, Toronto, Ontario. Revised February20, 2015.
-
(2015)
-
-
-
6
-
-
84911447847
-
Approach to the new oral anticoagulants in family practice, part 1: comparing the options (clinical review)
-
J.DouketisA.D.BellJ.EikelboomA.LiewApproach to the new oral anticoagulants in family practice, part 1: comparing the options (clinical review). Can Fam Physician2014;60:989-95.
-
(2014)
Can Fam Physician
, vol.60
, pp. 989-995
-
-
Douketis, J.1
Bell, A.D.2
Eikelboom, J.3
Liew, A.4
-
7
-
-
84911366554
-
Approach to the new oral anticoagulants in family practice, part 2: addressing frequently asked questions (clinical review)
-
J.DouketisA.D.BellJ.EikelboomA.LiewApproach to the new oral anticoagulants in family practice, part 2: addressing frequently asked questions (clinical review). Can Fam Physician2014;60:997-1001.
-
(2014)
Can Fam Physician
, vol.60
, pp. 997-1001
-
-
Douketis, J.1
Bell, A.D.2
Eikelboom, J.3
Liew, A.4
-
8
-
-
84893507765
-
A practice tool for the new oral anticoagulants
-
A.MassicotteA practice tool for the new oral anticoagulants. Can Pharm J (Ott)2014;147:25-32.
-
(2014)
Can Pharm J (Ott)
, vol.147
, pp. 25-32
-
-
Massicotte, A.1
-
9
-
-
32844472355
-
Is pulse palpation helpful in detecting atrial fibrillation? A systematic review
-
G.CookeJ.DoustS.SandersIs pulse palpation helpful in detecting atrial fibrillation? A systematic review. J Fam Practice2006;55:130-4.
-
(2006)
J Fam Practice
, vol.55
, pp. 130-134
-
-
Cooke, G.1
Doust, J.2
Sanders, S.3
-
10
-
-
84889058769
-
Pharmacokinetic and pharmacodynamic drug interactions with new oral anticoagulants: what do they mean for patients with atrial fibrillation?
-
T.HellwigM.GulsethPharmacokinetic and pharmacodynamic drug interactions with new oral anticoagulants: what do they mean for patients with atrial fibrillation?Ann Pharmacother2013;47:1478-87.
-
(2013)
Ann Pharmacother
, vol.47
, pp. 1478-1487
-
-
Hellwig, T.1
Gulseth, M.2
-
11
-
-
84919456547
-
Observational study of the effects of dabigatran on gastrointestinal symptoms in patients with non-valvular atrial fibrillation
-
T.YamashitaE.WatanabeT.Ikeda. Observational study of the effects of dabigatran on gastrointestinal symptoms in patients with non-valvular atrial fibrillation. J Arrhythmia2014;30:478-84.
-
(2014)
J Arrhythmia
, vol.30
, pp. 478-484
-
-
Yamashita, T.1
Watanabe, E.2
Ikeda, T.3
-
12
-
-
84940907442
-
Stability of dabigatran etexilate in manufacturer’s blister pack, unit dose packaging, and community pharmacy blister pack
-
E.H.Z.WangJ.L.BoltD.Decarie. Stability of dabigatran etexilate in manufacturer’s blister pack, unit dose packaging, and community pharmacy blister pack. Can J Hosp Pharm2015;68:16-21.
-
(2015)
Can J Hosp Pharm
, vol.68
, pp. 16-21
-
-
Wang, E.H.Z.1
Bolt, J.L.2
Decarie, D.3
|